GLSP mitigates vascular aging by promoting Sirt7-mediated Keap1 deacetylation and Keap1-Nrf2 dissociation

Yanfei Cheng1, Guobin Zheng2, Heming Huang3

  • 1First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.

Theranostics
|April 14, 2025
PubMed

Insights

Ganoderma lucidum spore powder (GLSP) delays vascular aging, atherosclerosis, and calcification by activating the Sirt7-Nrf2 pathway. This natural compound offers a new strategy to combat age-related vascular diseases.

Area of Science:

  • Gerontology and Cardiovascular Science
  • Pharmacology and Natural Products Research
  • Molecular Biology and Aging Mechanisms

Background:

  • Vascular aging is a key indicator of overall aging and a major driver of atherosclerosis and vascular calcification.
  • Current pharmacological interventions for vascular aging are limited, highlighting the need for novel therapeutic strategies.
  • Understanding the molecular pathways involved in vascular aging is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the anti-aging effects of Ganoderma lucidum spore powder (GLSP) on the vasculature.
  • To elucidate the molecular targets and mechanisms by which GLSP mitigates vascular aging, atherosclerosis, and calcification.
  • To evaluate the therapeutic potential of GLSP for age-related vascular conditions.

Main Methods:

  • Assessed GLSP's anti-vascular aging effects in aged C57BL/6J mice.
  • Identified GLSP targets using transcriptome sequencing and evaluated its protective effects on atherosclerosis and vascular calcification in relevant mouse models.
  • Investigated GLSP triterpenes' effects on vascular smooth muscle cells (VSMCs) in vitro, focusing on senescence and calcification.

Main Results:

  • GLSP demonstrated anti-vascular aging properties by regulating cell cycle, senescence-associated secretory phenotype (SASP), DNA damage, oxidative stress, mitochondrial function, and metabolism.
  • In vivo studies showed GLSP improved vascular aging-associated atherosclerosis and calcification.
  • Mechanistically, GLSP upregulated Sirt7, which interacted with Keap1, promoting Nrf2 activation via deacetylation and dissociation, thereby alleviating VSMC senescence and calcification.

Conclusions:

  • GLSP effectively alleviates vascular aging, atherosclerosis, and vascular calcification.
  • The primary mechanism involves antioxidant effects mediated by the activation of the Sirt7-Nrf2 signaling axis.
  • GLSP represents a promising natural therapeutic strategy for delaying vascular aging and associated diseases.